O’Melveny advised Samsung Display Co., Ltd on the transaction, while White & Case and Goodwin Procter advised eMagin. Samsung Display Co., Ltd, a subsidiary of Samsung...
You must be a Standard 1 Year member to access this content.
Goodwin advised Berkshire Grey, Inc. on the deal. Berkshire Grey, Inc. (Nasdaq: BGRY) announced its definitive merger agreement to be acquired by SoftBank Group Corp. and its...
You must be a Standard 1 Year member to access this content.
Goodwin advised OncoC4 on the deal. OncoC4 announced its agreement with BioNTech SE pursuant to which BioNTech receives an exclusive worldwide license to co-develop and commercialize OncoC4’s...
You must be a Standard 1 Year member to access this content.
AKD, Wiersholm, Houthoff, Schjødt, DLA Piper and Goodwin Procter advised Marlin Equity Partners on the deal, while Freshfields and Thomessen acted for Altor. Marlin Equity Partners,...
You must be a Standard 1 Year member to access this content.
Morgan Lewis represented Merck in the transaction. Merck closed its exclusive license and collaboration agreement with Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical Co. Ltd., to...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Wave Life Sciences on the deal. Wave Life Sciences (Nasdaq: WVE) announced its strategic collaboration with GSK (LSE/NYSE: GSK) to advance oligonucleotide therapeutics, including...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb represented Takeda in the transaction while Goodwin Procter advised Nimbus Therapeutics. Takeda (TSE:4502/NYSE:TAK) announced that it will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Entrada Therapeutics, Inc. on the deal. Entrada Therapeutics, Inc. (Nasdaq: TRDA) announced its global collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to focus...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Shopify on the matter while Goodwin represented Klaviyo. On August 2, 2022, Shopify announced it has made a $100 million...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Ping Identity, while Goodwin Procter represented Thoma Bravo in the transaction. Ping Identity (NYSE: PING), provider of the Intelligent Identity solution for...
You must be a Standard 1 Year member to access this content.
Goodwin advised Royalty Pharma plc on the deal. Royalty Pharma plc (Nasdaq: RPRX) announced its definitive agreement to acquire a royalty interest in TRELEGY ELLIPTA (Trelegy) from...
You must be a Standard 1 Year member to access this content.
